GLP-1 medication a novel treatment for binge eating disorders
New systematic review reveals GLP-1 medication as a novel treatment for binge eating disorders
.svg)
GLP-1 medication a novel treatment for binge eating disorders
New systematic review reveals GLP-1 medication as a novel treatment for binge eating disorders: Insights from Calle Mauritzson, Licensed Psychologist at Yazen.
A new study, published in the Journal of Clinical & Translational Endocrinology, has shown that treatment with GLP-1 medication is a promising novel approach for binge eating disorder and bulimia nervosa. Calle Mauritzson, licensed psychologist at the healthcare provider Yazen, provides his perspective on why the integration of GLP-1 medication in the treatment of these conditions seems so effective.
1. New understanding of binge eating and medical mechanisms: It’s crucial for care givers to understand how GLP-1 receptor agonists work. These medications can significantly reduce binge eating episodes by influencing the brain's appetite-regulating pathways, which helps in managing the disorder more effectively.
2. Regular meals with the aid of medicine: Combining regular meal patterns with the use of GLP-1 receptor agonists is essential. This approach helps stabilise appetite and prevent binge eating episodes, creating a structured eating routine that supports recovery.
3. Identify triggers and use medication as support: Using GLP-1 receptor agonists can reduce the physical urge to binge eat. Simultaneously, it's important for patients to work on identifying and managing their personal triggers and creating a comprehensive treatment plan.
4. Cognitive change and medication: Cognitive treatment becomes more effective when combined with medical treatment. GLP-1 receptor agonists can lessen the physical cravings, making it easier for patients to implement cognitive strategies and change negative thought patterns.
5. Alternative coping strategies and weight loss: Developing healthy coping strategies is vital. With the help of GLP-1 receptor agonists, patients can manage weight loss and improve their relationship with food, facilitating a healthier lifestyle
6. Physical activity with medical monitoring: Incorporating regular physical activity is an important part of the treatment plan. We need to consider the effects of GLP-1 receptor agonists on appetite and energy levels to tailor the physical activity to each patient’s needs."
7. Support network and medical treatment: A strong support network is invaluable. Emotional support from friends, family, or support groups, combined with the physiological benefits of GLP-1 receptor agonists, can greatly enhance the treatment process.
This comprehensive approach, integrating both medical treatment and behavioural strategies, provides a more effective and holistic treatment for patients struggling with binge eating disorder and bulimia nervosa.
Read the interesting review:
https://www.sciencedirect.com/science/article/pii/S2214623724000048
October 14, 2024
May 19, 2026
Start your weight loss journey with Yazen today
Everything you need to do is to create an account and answer some questions about your health
.svg)
.svg)
More articles
Mounjaro KwikPen – how the pre-filled injection pen works
KwikPen is a pre-filled multi-dose pen from the pharmaceutical company Eli Lilly, used to administer the medication Mounjaro. This type of pen is designed to facilitate regular dosing during medical weight loss and the treatment of type 2 diabetes. Here we go through how to handle the pen safely – from preparation to correct storage – to ensure your treatment works optimally.
Diabetes medicines, weight loss and long-term health
Searches for diabetes medicines and weight loss have risen sharply. Lots of people want to understand the connection and who this kind of treatment might be right for. Some medicines originally developed for type 2 diabetes can also lead to weight loss. In this article, we explain how diabetes medicines and weight loss are linked, and which treatments may help support weight loss.